Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases – where are we presently?
出版年份 2021 全文链接
标题
Retinoic acid-related orphan receptor gamma t (RORγt) inverse agonists/antagonists for the treatment of inflammatory diseases – where are we presently?
作者
关键词
-
出版物
Expert Opinion on Drug Discovery
Volume -, Issue -, Pages 1-19
出版商
Informa UK Limited
发表日期
2021-07-01
DOI
10.1080/17460441.2021.1948833
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Discovery of a Series of Pyrazinone RORγ Antagonists and Identification of the Clinical Candidate BI 730357
- (2021) Christian Harcken et al. ACS Medicinal Chemistry Letters
- Orthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand
- (2021) Femke A. Meijer et al. ACS Chemical Biology
- Tricyclic-Carbocyclic RORγt Inverse Agonists—Discovery of BMS-986313
- (2021) Michael G. Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial
- (2021) Kristian Reich et al. LANCET
- Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
- (2021) Kamran Ghoreschi et al. LANCET
- Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt
- (2021) Rens M. J. M. de Vries et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt
- (2020) Xin Jiang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid‐related orphan receptor γ agonist AZD0284
- (2020) Sara Asimus et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis
- (2020) Donatella Chianelli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases
- (2020) Hongjun Zhang et al. ACS Medicinal Chemistry Letters
- Emerging systemic drugs in the treatment of plaque psoriasis
- (2020) Esther A. Balogh et al. EXPERT OPINION ON EMERGING DRUGS
- Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
- (2020) Jean-François Dufour et al. GUT
- Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt
- (2020) Iris A. Leijten-van de Gevel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist
- (2020) Robert J. Cherney et al. ACS Medicinal Chemistry Letters
- Substituted benzyloxytricyclic compounds as retinoic acid-related orphan receptor gamma t (RORγt) agonists
- (2020) Lalgudi S. Harikrishnan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt
- (2020) Christian Gege et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery and optimization of new oxadiazole substituted thiazole RORγt inverse agonists through a bioisosteric amide replacement approach
- (2020) Christoph Steeneck et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A phase I, randomized, double‐blind study to assess the safety, tolerability, and efficacy of the topical RORC2 inverse agonist PF‐06763809 in participants with mild‐to‐moderate plaque psoriasis
- (2020) G. Berstein et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- RORγ Structural Plasticity and Druggability
- (2020) Mian Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Annulation reaction enables the identification of an exocyclic amide tricyclic chemotype as retinoic acid Receptor-Related orphan receptor gamma (RORγ/RORc) inverse agonists
- (2020) David Marcoux et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of 2,6–difluorobenzyl ether series of phenyl ((R)–3–phenylpyrrolidin–3–yl)sulfones as surprisingly potent, selective and orally bioavailable RORγt inverse agonists
- (2020) James J.-W. Duan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists
- (2020) Bin Jiang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems
- (2020) Vamshi Krishna Rapalli et al. DRUG DISCOVERY TODAY
- Tricyclic sulfones as potent, selective and efficacious RORγt inverse agonists – Exploring C6 and C8 SAR using late-stage functionalization
- (2020) Qing Shi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, Synthesis, and Biological Evaluation of Retinoic-Acid-Related Orphan Receptor γt (RORγt) Agonist -Structure-based functionality switching approach from in house RORγt inverse agonist to RORγt agonist-
- (2019) Tomoya Yukawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists
- (2019) James J.-W. Duan et al. ACS Medicinal Chemistry Letters
- Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold
- (2019) Masayuki Kotoku et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
- (2019) Jérôme Amaudrut et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease
- (2019) Keiko Igaki et al. INFLAMMATION RESEARCH
- Discovery of potent and orally bioavailable inverse agonists of the retinoic acid receptor-related orphan receptor C2
- (2019) Stefan von Berg et al. ACS Medicinal Chemistry Letters
- Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists
- (2019) Zhonghui Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 3-Substituted Quinolines as RORγt Inverse Agonists
- (2019) Virginia M. Tanis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain
- (2019) James R. Burke et al. Science Translational Medicine
- (Inverse) Agonists of Retinoic Acid–Related Orphan Receptor γ: Regulation of Immune Responses, Inflammation, and Autoimmune Disease
- (2019) Anton M. Jetten et al. Annual Review of Pharmacology and Toxicology
- 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt
- (2019) Chuyu Lao et al. BIOORGANIC CHEMISTRY
- Retinoic acid receptor-related orphan receptor gamma-t (RORγt) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)
- (2019) Nannan Sun et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Inhibition of Interleukin-23–Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt
- (2019) Stephen B. Gauld et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Design and Synthesis of Conformationally Constrained RORγt Inverse Agonists
- (2019) Ayumu Sato et al. ChemMedChem
- Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt—Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy
- (2019) David Marcoux et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological evaluation of TAK-828F, a novel orally available RORγt inverse agonist, on murine chronic experimental autoimmune encephalomyelitis model
- (2019) Yoshiki Nakamura et al. JOURNAL OF NEUROIMMUNOLOGY
- IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases
- (2019) Arun K. Kannan et al. Scientific Reports
- Ligand-Based Design of Allosteric Retinoic Acid Receptor-Related Orphan Receptor γt (RORγt) Inverse Agonists
- (2019) Femke A. Meijer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist
- (2018) Akira Shibata et al. BIOCHEMICAL PHARMACOLOGY
- Identification of novel quinazolinedione derivatives as RORγt inverse agonist
- (2018) Yoshiyuki Fukase et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of orally efficacious RORγt inverse agonists, part 1: Identification of novel phenylglycinamides as lead scaffolds
- (2018) Junya Shirai et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives
- (2018) Mitsunori Kono et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Identification and biological evaluation of thiazole-based inverse agonists of RORγt
- (2018) Christian Gege et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
- (2018) Hua Gong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test
- (2018) E.G. Kang et al. BRITISH JOURNAL OF DERMATOLOGY
- Discovery and Characterization of CD12681, a Potent RORγ Inverse Agonist, Preclinical Candidate for the Topical Treatment of Psoriasis
- (2018) Gilles Ouvry et al. ChemMedChem
- Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
- (2018) Vrajesh Bhaskarbhai Pandya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of [cis-3-({(5R)-5-[(7-Fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl]-2-methoxy-7,8-dihydro-1,6-naphthyridin-6(5H)-yl}carbonyl)cyclobutyl]acetic Acid (TAK-828F) as a Potent, Selective, and Orally Available Novel Retinoic Acid Receptor-Related Orphan Receptor γt Inverse Agonist
- (2018) Mitsunori Kono et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Conduct Considerations for First-in-Human Trials
- (2018) Jie Shen et al. CTS-Clinical and Translational Science
- Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model
- (2018) Keiko Igaki et al. INFLAMMATION
- Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design
- (2018) Frank Narjes et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist
- (2018) Mark E. Schnute et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biochemical Properties of TAK-828F, a Potent and Selective Retinoid-Related Orphan Receptor Gamma t Inverse Agonist
- (2018) Hideyuki Nakagawa et al. PHARMACOLOGY
- A Drug with Lipophilicity-Dependent Potency Can Be Metabolically Stable: Discovery of a Potent and Selective Retinoic Acid Receptor-Related Orphan Receptor C2 (RORC2) Inverse Agonist as an Orally Bioavailable Anti-Inflammatory Agent
- (2018) Yibing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients
- (2018) Koen Venken et al. Nature Communications
- Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction
- (2018) Masato Noguchi et al. Scientific Reports
- An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients
- (2018) Helena Bassolas-Molina et al. Frontiers in Immunology
- Ternary complex of human RORγ ligand-binding domain, inverse agonist and SMRT peptide shows a unique mechanism of corepressor recruitment
- (2017) Masato Noguchi et al. GENES TO CELLS
- Psoriasis pathogenesis and the development of novel targeted immune therapies
- (2017) Jason E. Hawkes et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Characterization of a new pathway that activates lumisterol in vivo to biologically active hydroxylumisterols
- (2017) Andrzej T. Slominski et al. Scientific Reports
- Recent progress on nuclear receptor RORγ modulators
- (2016) Patrick Cyr et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of phenoxyindazoles and phenylthioindazoles as RORγ inverse agonists
- (2016) Gilles Ouvry et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Retinoid-related orphan receptor gamma t (RORγt) inhibitors from Vitae Pharmaceuticals (WO2015116904) and structure proposal for their Phase I candidate VTP-43742
- (2016) Christian Gege EXPERT OPINION ON THERAPEUTIC PATENTS
- RORγt inhibitors as potential back-ups for the phase II candidate VTP-43742 from Vitae Pharmaceuticals: patent evaluation of WO2016061160 and US20160122345
- (2016) Christian Gege EXPERT OPINION ON THERAPEUTIC PATENTS
- RORγ antagonists and inverse agonists: a patent review
- (2016) Sarah M. Bronner et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- RORγt inhibitors suppress TH17 responses in inflammatory arthritis and inflammatory bowel disease
- (2016) Jelle de Wit et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
- (2016) Junjian Wang et al. NATURE MEDICINE
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- IL-17 in Chronic Inflammation: From Discovery to Targeting
- (2016) Audrey Beringer et al. TRENDS IN MOLECULAR MEDICINE
- Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity
- (2016) Yanxia Guo et al. Cell Reports
- Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin
- (2016) Susan H. Smith et al. PLoS One
- Pharmacologic modulation of RORγt translates to efficacy in preclinical and translational models of psoriasis and inflammatory arthritis
- (2016) Xiaohua Xue et al. Scientific Reports
- Discovery of N -(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists
- (2015) Yonghui Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists
- (2015) Benjamin P. Fauber et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ
- (2015) Roine I. Olsson et al. ChemMedChem
- Retinoid-related orphan receptor γ t modulators: comparison of Glenmark’s me-too patent application (WO2015008234) with the originator application from Merck Sharp and Dohme (WO2012106995)
- (2015) Christian Gege EXPERT OPINION ON THERAPEUTIC PATENTS
- Are Th17 cells and their cytokines a therapeutic target in Guillain–Barré syndrome?
- (2015) Xiujuan Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The promise and peril of chemical probes
- (2015) Cheryl H Arrowsmith et al. Nature Chemical Biology
- Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors
- (2015) Yonghui Wang et al. ACS Medicinal Chemistry Letters
- SAR Exploration Guided by LE and Fsp3: Discovery of a Selective and Orally Efficacious RORγ Inhibitor
- (2015) Kazuyuki Hirata et al. ACS Medicinal Chemistry Letters
- Identification of an allosteric binding site for RORγt inhibition
- (2015) Marcel Scheepstra et al. Nature Communications
- ROR nuclear receptors: structures, related diseases and drug discovery
- (2014) Yan Zhang et al. ACTA PHARMACOLOGICA SINICA
- Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt
- (2014) Christian Gege et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Pharmacologic Inhibition of ROR t Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo
- (2014) J. Skepner et al. JOURNAL OF IMMUNOLOGY
- Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
- (2014) Benjamin P. Fauber et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent RORγt inhibitors
- (2013) Yonghui Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Exploratory toxicology as an integrated part of drug discovery. Part II: Screening strategies
- (2013) Jorrit J. Hornberg et al. DRUG DISCOVERY TODAY
- Exploratory toxicology as an integrated part of drug discovery. Part I: Why and how
- (2013) Jorrit J. Hornberg et al. DRUG DISCOVERY TODAY
- The orphan nuclear receptors at their 25-year reunion
- (2013) Shannon E Mullican et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Pharmacologic Repression of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γ Is Therapeutic in the Collagen-Induced Arthritis Experimental Model
- (2013) Mi Ra Chang et al. Arthritis & Rheumatology
- Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator
- (2012) Naresh Kumar et al. ACS Chemical Biology
- Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity
- (2012) Thomas P. Burris et al. CHEMISTRY & BIOLOGY
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- (2011) Laura A. Solt et al. NATURE
- The Benzenesulfoamide T0901317 [N-(2,2,2-Trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] Is a Novel Retinoic Acid Receptor-Related Orphan Receptor- / Inverse Agonist
- (2009) N. Kumar et al. MOLECULAR PHARMACOLOGY
- Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: A novel pro-drug approach to increase exposure
- (2008) Gregory S. Basarab et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started